Why AI matters at this scale

AEG Vision is a large, rapidly growing network of ophthalmology and optometry practices, founded in 2017 and now spanning over 100 locations with 1,000–5,000 employees. The company operates at a critical inflection point: its scale generates massive, standardized clinical and operational data, but its mid-market size and private equity backing demand efficient scaling and clear profitability. In the competitive, procedure-driven eye care sector, AI is not a futuristic concept but a necessary tool to unlock margin expansion, differentiate clinical quality, and manage complexity across a decentralized network. For AEG, AI adoption represents a strategic lever to transition from a roll-up aggregator to a tech-enabled, integrated healthcare delivery platform.

Concrete AI Opportunities with ROI Framing

1. Diagnostic AI for Scalable Specialty Care: Implementing FDA-cleared AI for diabetic retinopathy screening and exploring algorithms for glaucoma and AMD detection can create a high-margin, scalable screening service. ROI comes from increased patient throughput per technician, potential new reimbursement codes for AI-assisted screening, and improved patient outcomes that drive retention and referrals. The upfront cost of software and integration is offset by reducing the burden on high-cost ophthalmologists for routine screenings.

2. Operational AI for Network Efficiency: Machine learning models applied to historical scheduling, surgical duration, and supply chain data can predict demand with high accuracy. For a network performing thousands of monthly procedures, optimizing operating room blocks and lens inventory across locations can directly improve revenue per OR hour and reduce costly expedited shipping and waste. A 10% improvement in asset utilization could translate to millions in annual EBITDA contribution.

3. Patient Journey Personalization: AI-driven patient communication platforms can automate pre-appointment instructions, post-operative follow-ups, and chronic condition management (e.g., dry eye). This improves patient satisfaction and adherence while freeing up staff time. The ROI is realized through reduced no-show rates, improved surgical outcomes leading to fewer complications, and enhanced lifetime patient value through increased engagement and cross-selling of services like premium lenses.

Deployment Risks Specific to This Size Band

For a company of AEG's size, the primary deployment risks are integration, governance, and talent. The network likely uses a mix of practice management (PM) and electronic health record (EHR) systems, making centralized data aggregation for AI training a significant technical hurdle. A phased integration strategy, starting with the most common PM system, is essential. Secondly, clinical AI tools require robust governance: clear protocols for clinician oversight, liability frameworks, and continuous performance monitoring to avoid model drift. Finally, attracting and retaining data science and clinical informatics talent is challenging for mid-market healthcare companies competing with tech giants and large hospital systems. A partnership-first approach with established AI vendors may mitigate this talent gap, but requires careful vendor management to avoid lock-in and ensure the solutions are tailored to AEG's specific workflows and patient demographics.